Carrier proteins-based boron delivery to tumor

Shunsuke Kikuchi, Shinichi Sato, Hiroyuki Nakamura

Research output: Contribution to journalArticlepeer-review

Abstract

The conjugation of maleimide-functionalized closo-dodecaborate (MID) to transferrin (TF), which has no free SH cysteine residue, proceeded at room temperature for 12 h in PBS buffer (pH = 7.4). MID-TF conjugates were accumulated into the cells in the time- and concentration-dependent manners through the TF receptor mediated mechanism. In vivo biodistribution study of MID-TF conjugates in colon 26-bearing mice revealed the time-dependent selective accumulation of MID-TF conjugates into tumor very similar to that of MID-BSA. The tumor boron concentration of MID-BSA was higher than that of MID-TF conjugates (62 ppm vs. 20 ppm at a dose of 30 mg [B]/kg) 12 h after administration, suggesting that the EPR effect is not remarkably observed in the case of MID-TF conjugates because TF has smaller molecular weight than BSA (48 kDa vs. 68 kDa).

Original languageEnglish
Article number109011
JournalApplied Radiation and Isotopes
Volume157
DOIs
Publication statusPublished - 2020 Mar
Externally publishedYes

ASJC Scopus subject areas

  • Radiation

Fingerprint Dive into the research topics of 'Carrier proteins-based boron delivery to tumor'. Together they form a unique fingerprint.

Cite this